{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:43:48Z","timestamp":1793774628601,"version":"4.6.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10549-019-05443-1","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T17:03:41Z","timestamp":1568826221000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Patient-reported outcomes and objective assessments with arm measurement and bioimpedance analysis for lymphedema among breast cancer survivors"],"prefix":"10.1007","volume":"179","author":[{"given":"Mitsuo","family":"Terada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5274-9158","authenticated-orcid":false,"given":"Akiyo","family":"Yoshimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Sawaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gondo","family":"Naomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruru","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayoi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayoko","family":"Sugino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanae","family":"Horisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroji","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"5443_CR1","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1245\/s10434-013-3408-5","volume":"21","author":"JC Boughey","year":"2014","unstructured":"Boughey JC, Hoskin TL, Cheville AL, Miller J, Loprinzi MD, Thomsen KM, Maloney S, Baddour LM, Degnim AC (2014) Risk factors associated with breast lymphedema. Ann Surg Oncol 21:1202\u20131208. \nhttps:\/\/doi.org\/10.1245\/s10434-013-3408-5","journal-title":"Ann Surg Oncol"},{"key":"5443_CR2","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1200\/JCO.2008.16.3725","volume":"26","author":"SA McLaughlin","year":"2008","unstructured":"McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, Hurley KE, Riedel ER, Van Zee KJ (2008) Prevalence of lymphedema in women with breast cancer 5\u00a0years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26:5213\u20135219. \nhttps:\/\/doi.org\/10.1200\/JCO.2008.16.3725","journal-title":"J Clin Oncol"},{"key":"5443_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/1097-0142(20010815)92:4<748::aid-cncr1378>3.0.co;2-v","volume":"92","author":"SF Sener","year":"2001","unstructured":"Sener SF, Winchester DJ, Martz CH, Feldman JL, Cavanaugh JA, Winchester DP, Weigel B, Bonnefoi K, Kirby K, Morehead C (2001) Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92:748\u2013752. \nhttps:\/\/doi.org\/10.1002\/1097-0142(20010815)92:4%3c748:aid-cncr1378%3e3.0.co;2-v","journal-title":"Cancer"},{"key":"5443_CR4","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1002\/(sici)1097-0142(19981215)83:12b+<2814::aid-cncr31>3.3.co;2-5","volume":"83","author":"SG Rockson","year":"1998","unstructured":"Rockson SG (1998) Precipitating factors in lymphedema: myths and realities. Cancer 83:2814\u20132816. \nhttps:\/\/doi.org\/10.1002\/(sici)1097-0142(19981215)83:12b+%3c2814:aid-cncr31%3e3.3.co;2-5","journal-title":"Cancer"},{"key":"5443_CR5","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1245\/s10434-017-5982-4","volume":"24","author":"SA McLaughlin","year":"2017","unstructured":"McLaughlin SA, Staley AC, Vicini F, Thiruchelvam P, Hutchison NA, Mendez J, MacNeill F, Rockson SG, DeSnyder SM, Klimberg S, Alatriste M, Boccardo F, Smith ML, Feldman SM (2017) Considerations for clinicians in the diagnosis, prevention, and treatment of breast cancer-related lymphedema: recommendations from a multidisciplinary expert ASBrS panel: Part 1: Definitions, assessments, education, and future directions. Ann Surg Oncol 24:2818\u20132826. \nhttps:\/\/doi.org\/10.1245\/s10434-017-5982-4","journal-title":"Ann Surg Oncol"},{"key":"5443_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s11764-012-0247-5","volume":"7","author":"AL Pusic","year":"2013","unstructured":"Pusic AL, Cemal Y, Albornoz C, Klassen A, Cano S, Sulimanoff I, Hernandez M, Massey M, Cordeiro P, Morrow M, Mehrara B (2013) Quality of life among breast cancer patients with lymphedema: a systematic review of patient-reported outcome instruments and outcomes. J Cancer Surviv 7:83\u201392. \nhttps:\/\/doi.org\/10.1007\/s11764-012-0247-5","journal-title":"J Cancer Surviv"},{"key":"5443_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ejso.2014.12.006","volume":"41","author":"H Sackey","year":"2015","unstructured":"Sackey H, Johansson H, Sandelin K, Liljegren G, MacLean G, Frisell J, Brandberg Y (2015) Self-perceived, but not objective lymphoedema is associated with decreased long-term health-related quality of life after breast cancer surgery. Eur J Surg Oncol 41:577\u2013584. \nhttps:\/\/doi.org\/10.1016\/j.ejso.2014.12.006","journal-title":"Eur J Surg Oncol"},{"key":"5443_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10549-015-3357-8","volume":"151","author":"NJ Bundred","year":"2015","unstructured":"Bundred NJ, Stockton C, Keeley V, Riches K, Ashcroft L, Evans A, Skene A, Purushotham A, Bramley M, Hodgkiss T, Investigators of BEA, PLACE studies (2015) Comparison of multi-frequency bioimpedance with perometry for the early detection and intervention of lymphoedema after axillary node clearance for breast cancer. Breast Cancer Res Treat 151:121\u2013129. \nhttps:\/\/doi.org\/10.1007\/s10549-015-3357-8","journal-title":"Breast Cancer Res Treat"},{"key":"5443_CR9","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/lrb.2017.0070","volume":"16","author":"SH Ridner","year":"2018","unstructured":"Ridner SH, Dietrich MS, Spotanski K, Doersam JK, Cowher MS, Taback B, McLaughlin S, Ajkay N, Boyages J, Koelmeyer L, DeSnyder S, Shah C, Vicini F (2018) A prospective study of L-dex values in breast cancer patients pretreatment and through 12\u00a0months postoperatively. Lymphat Res Biol 16:435\u2013441. \nhttps:\/\/doi.org\/10.1089\/lrb.2017.0070","journal-title":"Lymphat Res Biol"},{"key":"5443_CR10","doi-asserted-by":"publisher","first-page":"687","DOI":"10.5535\/arm.2011.35.5.687","volume":"35","author":"L Kim","year":"2011","unstructured":"Kim L, Jeon JY, Sung IY, Jeong SY, Do JH, Kim HJ (2011) Prediction of treatment outcome with bioimpedance measurements in breast cancer related lymphedema patients. Ann Rehabil Med 35:687\u2013693. \nhttps:\/\/doi.org\/10.5535\/arm.2011.35.5.687","journal-title":"Ann Rehabil Med"},{"key":"5443_CR11","first-page":"85","volume":"46","author":"MR Fu","year":"2013","unstructured":"Fu MR, Cleland CM, Guth AA, Kayal M, Haber J, Cartwright F, Kleinman R, Kang Y, Scagliola J, Axelrod D (2013) L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity. Lymphology 46:85\u201396","journal-title":"Lymphology"},{"key":"5443_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/lrb.2010.0014","volume":"9","author":"LC Ward","year":"2011","unstructured":"Ward LC, Dylke E, Czerniec S, Isenring E, Kilbreath SL (2011) Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphat Res Biol 9:47\u201351. \nhttps:\/\/doi.org\/10.1089\/lrb.2010.0014","journal-title":"Lymphat Res Biol"},{"key":"5443_CR13","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1080\/0284186X.2016.1191668","volume":"55","author":"ES Dylke","year":"2016","unstructured":"Dylke ES, Schembri GP, Bailey DL, Bailey E, Ward LC, Refshauge K, Beith J, Black D, Kilbreath SL (2016) Diagnosis of upper limb lymphedema: development of an evidence-based approach. Acta Oncol 55:1477\u20131483. \nhttps:\/\/doi.org\/10.1080\/0284186X.2016.1191668","journal-title":"Acta Oncol"},{"key":"5443_CR14","first-page":"2","volume":"34","author":"BH Cornish","year":"2001","unstructured":"Cornish BH, Chapman M, Hirst C, Mirolo B, Bunce IH, Ward LC, Thomas BJ (2001) Early diagnosis of lymphedema using multiple frequency bioimpedance. Lymphology 34:2\u201311","journal-title":"Lymphology"},{"key":"5443_CR15","first-page":"170","volume":"49","author":"Executive Committee","year":"2016","unstructured":"Committee Executive (2016) The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology. Lymphology 49:170\u2013184","journal-title":"Lymphology"},{"key":"5443_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/lrb.2014.0035","volume":"12","author":"A Soran","year":"2014","unstructured":"Soran A, Ozmen T, McGuire KP, Diego EJ, McAuliffe PF, Bonaventura M, Ahrendt GM, DeGore L, Johnson R (2014) The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection; a prospective observational study. Lymphat Res Biol 12:289\u2013294. \nhttps:\/\/doi.org\/10.1089\/lrb.2014.0035","journal-title":"Lymphat Res Biol"},{"key":"5443_CR17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/00006199-200311000-00004","volume":"52","author":"JM Armer","year":"2003","unstructured":"Armer JM, Radina ME, Porock D, Culbertson SD (2003) Predicting breast cancer-related lymphedema using self-reported symptoms. Nurs Res 52:370\u2013379. \nhttps:\/\/doi.org\/10.1097\/00006199-200311000-00004","journal-title":"Nurs Res"},{"key":"5443_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10549-004-2045-x","volume":"89","author":"S Hayes","year":"2005","unstructured":"Hayes S, Cornish B, Newman B (2005) Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up. Breast Cancer Res Treat 89:221\u2013226. \nhttps:\/\/doi.org\/10.1007\/s10549-004-2045-x","journal-title":"Breast Cancer Res Treat"},{"key":"5443_CR19","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.ejso.2011.09.001","volume":"37","author":"TR Lopez Penha","year":"2011","unstructured":"Lopez Penha TR, Slangen JJG, Heuts EM, Voogd AC, Von Meyenfeldt MF (2011) Prevalence of lymphoedema more than five years after breast cancer treatment. Eur J Surg Oncol 37:1059\u20131063. \nhttps:\/\/doi.org\/10.1016\/j.ejso.2011.09.001","journal-title":"Eur J Surg Oncol"},{"key":"5443_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/clc.23118","volume":"42","author":"E Thomas","year":"2019","unstructured":"Thomas E, Gupta PP, Fonarow GC, Horwich TB (2019) Bioelectrical impedance analysis of body composition and survival in patients with heart failure. Clin Cardiol 42:129\u2013135. \nhttps:\/\/doi.org\/10.1002\/clc.23118","journal-title":"Clin Cardiol"},{"key":"5443_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1536\/ihj.53.11","volume":"53","author":"MH Liu","year":"2012","unstructured":"Liu MH, Wang CH, Huang YY, Tung TH, Lee CM, Yang NI, Wang JS, Kuo LT, Cherng WJ (2012) Edema index-guided disease management improves 6-month outcomes of patients with acute heart failure. Int Heart J 53:11\u201317. \nhttps:\/\/doi.org\/10.1536\/ihj.53.11","journal-title":"Int Heart J"},{"key":"5443_CR22","doi-asserted-by":"publisher","first-page":"e0147070","DOI":"10.1371\/journal.pone.0147070","volume":"11","author":"SH Kang","year":"2016","unstructured":"Kang SH, Choi EW, Park JW, Cho KH, Do JY (2016) Clinical significance of the edema index in incident peritoneal dialysis patients. PLoS ONE 11:e0147070. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0147070","journal-title":"PLoS ONE"},{"key":"5443_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/MAT.0000000000000619","volume":"64","author":"CR Kim","year":"2018","unstructured":"Kim CR, Shin JH, Hwang JH, Kim SH (2018) Monitoring volume status using bioelectrical impedance analysis in chronic hemodialysis patients. ASAIO J 64:245\u2013252. \nhttps:\/\/doi.org\/10.1097\/MAT.0000000000000619","journal-title":"ASAIO J"},{"key":"5443_CR24","doi-asserted-by":"publisher","first-page":"e53294","DOI":"10.1371\/journal.pone.0053294","volume":"8","author":"Q Guo","year":"2013","unstructured":"Guo Q, Yi C, Li J, Wu X, Yang X, Yu X (2013) Prevalence and risk factors of fluid overload in Southern Chinese continuous ambulatory peritoneal dialysis patients. PLoS ONE 8:e53294. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0053294","journal-title":"PLoS ONE"},{"key":"5443_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3747\/pdi.2014.00008","volume":"35","author":"Q Guo","year":"2015","unstructured":"Guo Q, Lin J, Li J, Yi C, Mao H, Yang X, Yu X (2015) The effect of fluid overload on clinical outcome in Southern Chinese patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 35:691\u2013702. \nhttps:\/\/doi.org\/10.3747\/pdi.2014.00008","journal-title":"Perit Dial Int"},{"key":"5443_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejso.2007.05.017","volume":"34","author":"P Del Bianco","year":"2008","unstructured":"Del Bianco P, Zavagno G, Burelli P, Scalco G, Barutta L, Carraro P, Pietrarota P, Meneghini G, Morbin T, Tacchetti G, Pecoraro P, Belardinelli V, De Salvo GL, GIVOM (2008) Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the Sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34:508\u2013513. \nhttps:\/\/doi.org\/10.1016\/j.ejso.2007.05.017","journal-title":"Eur J Surg Oncol"},{"key":"5443_CR27","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/BF02574496","volume":"9","author":"KK Swenson","year":"2002","unstructured":"Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM (2002) Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 9:745\u2013753. \nhttps:\/\/doi.org\/10.1007\/BF02574496","journal-title":"Ann Surg Oncol"},{"key":"5443_CR28","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1001\/archsurg.138.5.482","volume":"138","author":"DK Blanchard","year":"2003","unstructured":"Blanchard DK, Donohue JH, Reynolds C, Grant CS (2003) Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138:482\u2013487. \nhttps:\/\/doi.org\/10.1001\/archsurg.138.5.482\n\ndiscussion 487\u2013488","journal-title":"Arch Surg"},{"key":"5443_CR29","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/(sici)1097-0142(20000201)88:3<608::aid-cncr17>3.0.co;2-k","volume":"88","author":"P Schrenk","year":"2000","unstructured":"Schrenk P, Rieger R, Shamiyeh A, Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608\u2013614. \nhttps:\/\/doi.org\/10.1002\/(sici)1097-0142(20000201)88:3%3c608:aid-cncr17%3e3.0.co;2-k","journal-title":"Cancer"},{"key":"5443_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/jso.20373","volume":"92","author":"M Leidenius","year":"2005","unstructured":"Leidenius M, Leivonen M, Vironen J, von Smitten K (2005) The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 92:23\u201331. \nhttps:\/\/doi.org\/10.1002\/jso.20373","journal-title":"J Surg Oncol"},{"key":"5443_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.breast.2004.09.010","volume":"14","author":"R R\u00f6nk\u00e4","year":"2005","unstructured":"R\u00f6nk\u00e4 R, von Smitten K, Tasmuth T, Leidenius M (2005) One-year morbidity after sentinel node biopsy and breast surgery. Breast 14:28\u201336. \nhttps:\/\/doi.org\/10.1016\/j.breast.2004.09.010","journal-title":"Breast"},{"key":"5443_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, Yiangou C, Horgan K, Bundred N, Monypenny I, England D, Sibbering M, Abdullah TI, Barr L, Chetty U, Sinnett DH, Fleissig A, Clarke D, Ell PJ (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599\u2013609. \nhttps:\/\/doi.org\/10.1093\/jnci\/djj158","journal-title":"J Natl Cancer Inst"},{"key":"5443_CR33","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","volume":"25","author":"A Lucci","year":"2007","unstructured":"Lucci A, McCall LM, Beitsch PD, Whitworth PW, Reintgen DS, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Giuliano AE, American College of Surgeons Oncology (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25:3657\u20133663. \nhttps:\/\/doi.org\/10.1200\/JCO.2006.07.4062","journal-title":"J Clin Oncol"},{"key":"5443_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1015234318582","volume":"73","author":"A Haid","year":"2002","unstructured":"Haid A, K\u00f6berle-W\u00fchrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G (2002) Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73:31\u201336. \nhttps:\/\/doi.org\/10.1023\/A:1015234318582","journal-title":"Breast Cancer Res Treat"},{"key":"5443_CR35","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJ, Mansel RE, Cataliotti L, Westenberg AH, Klinkenbijl JH, Orzalesi L, Bouma WH, van der Mijle HC, Nieuwenhuijzen GA, Veltkamp SC, Slaets L, Duez NJ, de Graaf PW, van Dalen T, Marinelli A, Rijna H, Snoj M, Bundred NJ, Merkus JW, Belkacemi Y, Petignat P, Schinagl DA, Coens C, Messina CG, Bogaerts J, Rutgers EJ (2014) Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981\u201322023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol 15:1303\u20131310. \nhttps:\/\/doi.org\/10.1016\/S1470-2045(14)70460-7","journal-title":"Lancet Oncol"},{"key":"5443_CR36","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/1097-0142(20010915)92:6<1368::aid-cncr1459>3.0.co;2-9","volume":"92","author":"JA Petrek","year":"2001","unstructured":"Petrek JA, Senie RT, Peters M, Rosen PP (2001) Lymphedema in a cohort of breast carcinoma survivors 20\u00a0years after diagnosis. Cancer 92:1368\u20131377. \nhttps:\/\/doi.org\/10.1002\/1097-0142(20010915)92:6%3c1368:aid-cncr1459%3e3.0.co;2-9","journal-title":"Cancer"},{"key":"5443_CR37","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1245\/s10434-006-9334-z","volume":"14","author":"RH Baron","year":"2007","unstructured":"Baron RH, Fey JV, Borgen PI, Stempel MM, Hardick KR, Van Zee KJ (2007) Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Ann Surg Oncol 14:1653\u20131661. \nhttps:\/\/doi.org\/10.1245\/s10434-006-9334-z","journal-title":"Ann Surg Oncol"},{"key":"5443_CR38","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/ejcn.2015.90","volume":"69","author":"K Panorchan","year":"2015","unstructured":"Panorchan K, Nongnuch A, El-Kateb S, Goodlad C, Davenport A (2015) Changes in muscle and fat mass with haemodialysis detected by multi-frequency bioelectrical impedance analysis. Eur J Clin Nutr 69:1109\u20131112. \nhttps:\/\/doi.org\/10.1038\/ejcn.2015.90","journal-title":"Eur J Clin Nutr"},{"issue":"Suppl 1","key":"5443_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/ggi.12212","volume":"14","author":"Y Yamada","year":"2014","unstructured":"Yamada Y, Matsuda K, Bj\u00f6rkman MP, Kimura M (2014) Application of segmental bioelectrical impedance spectroscopy to the assessment of skeletal muscle cell mass in elderly men. Geriatr Gerontol Int 14(Suppl 1):129\u2013134. \nhttps:\/\/doi.org\/10.1111\/ggi.12212","journal-title":"Geriatr Gerontol Int"},{"key":"5443_CR40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/lrb.2008.1022","volume":"7","author":"H Brorson","year":"2009","unstructured":"Brorson H, Ohlin K, Olsson G, Karlsson MK (2009) Breast cancer-related chronic arm lymphedema is associated with excess adipose and muscle tissue. Lymphat Res Biol 7:3\u201310. \nhttps:\/\/doi.org\/10.1089\/lrb.2008.1022","journal-title":"Lymphat Res Biol"},{"key":"5443_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1093\/ptj\/86.2.205","volume":"86","author":"R Taylor","year":"2006","unstructured":"Taylor R, Jayasinghe UW, Koelmeyer L, Ung O, Boyages J (2006) Reliability and validity of arm volume measurements for assessment of lymphedema. Phys Ther 86:205\u2013214","journal-title":"Phys Ther"},{"key":"5443_CR42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/00015458.2009.11680407","volume":"109","author":"A Gyedu","year":"2009","unstructured":"Gyedu A, Kepenekci I, Alic B, Akyar S (2009) Evaluation of muscle atrophy after axillary lymph node dissection. Acta Chir Belg 109:209\u2013215. \nhttps:\/\/doi.org\/10.1080\/00015458.2009.11680407","journal-title":"Acta Chir Belg"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05443-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05443-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05443-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T08:40:22Z","timestamp":1600332022000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05443-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["5443"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05443-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"31 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed involving human participants were in accordance with the ethical standards of the Institutional Review Board of Aichi Cancer Center and with the 1964 Helsinki declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}